Economic toxicity studies in patients with head and neck cancer:a scoping review
10.3760/cma.j.cn211501-20231012-00732
- VernacularTitle:头颈部肿瘤患者经济毒性研究的范围综述
- Author:
Ping XU
1
;
Miaomiao ZHANG
;
Rong YAN
;
Kai JIANG
;
Wenhui LIU
;
Jun′ai XIANG
Author Information
1. 山东第一医科大学护理学院，济南 250000
- Keywords:
Head and neck neoplasms;
Financial toxicity;
Risk factors;
Scoping review
- From:
Chinese Journal of Practical Nursing
2024;40(30):2394-2401
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To understand the status, evaluation methods and risk factors of economic toxicity in patients with head and neck cancer, in order to provide reference for the construction of follow-up intervention programs.Methods:This scoping review was conducted under the Joanna Briggs Institute in Australia guidelines. Relevant studies were searched in PubMed, Embase, Web of Science, Cochrane Library, Scopus, CINAHL, China National Knowledge Infrastructure, Wanfang Database, VIP Database and Chinese Biomedical Literature Database. Chinese and English literature was screened and summarized from inception to September 21, 2023.Results:A total of 14 articles were included, and the economic toxicity of patients with head and neck cancer was more serious.The evaluation methods were mainly divided into scale evaluation and database data calculation. The risk factors of economic toxicity in patients with head and neck cancer included three aspects: demographic factors such as young age, low education and low income; disease and treatment-related factors such as tumor location in larynx/hypopharynx, current/past use of tube feeding, advanced tumor/distant metastasis; social support factors such as insufficient social security, and so on.Conclusions:Future studies should pay more attention to economic toxicity in patients with head and neck cancer, standardize the selection of assessment tools to reduce heterogeneity, and develop individualized intervention measures for the risk factors of economic toxicity in patients with head and neck cancer, in order to reduce the occurrence of economic toxicity in patients with head and neck cancer.
